8-K: Current report
8-K: Current report
8-K: BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
10-Q: Quarterly report
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Officer Altman Peter
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | DEF 14A: Definitive information statements
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Phillip Frost, M.D.(4.8%),Frost Gamma Investments Trust(4.8%)
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | EFFECT: Others
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Officer Altman Peter
CORRESP: CORRESP
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 10-K: Annual report
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 8-K: BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 8-K: Current report
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 8-K: Current report
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 8-K: Current report
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | 8-K: Current report
Biocardia Inc C/Wts 06/08/2024(To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Phillip Frost, M.D.(6.1%),Frost Gamma Investments Trust(6.1%)
No Data